Mobilisation of neutrophils and premature photoaging in chronic vitiligenous skin of black skinned patients - Neutrophil mobilisation and premature photoaging in vitiligo / Vitphotoag

niversitair Medisch Centrum Utrecht0 个研究点目标入组 12 人开始时间: 待定最近更新: 2024年8月12日

适应症

试验速览

暂无简介。

•Group I and II: adult, male or female, aged 18 years or over; patients with skin phototype VI and vitiligo; the patient must be willing and able to give written informed consent.
•Group I specifically: chronic vitiligo, persistant for 10 years or more, localised on sunexposed skin.
•Group II specifically: it must be technically possible to determine the minimal erythemal dose.

•sunlight allergy; tendency to hypertrophic scar or keloid formation; history of alcohol or drug abuse; treatment with phototherapy or systemic (immunosuppressive) therapy such as oral steroids and cyclosporin A during the study, or within 24 weeks prior to the study; treatment with oral and local antibiotics; treatment with topical steroids or tar in the tested locations during the last 2 weeks; clinically relevant cardiovascular, gastrointestinal, liver or renal disease and/or unstable metabolic or endocrine disorders; acute or chronic local bacterial, viral or fungal diseases; women of childbearing potential not using reliable contraception; pregnancy or breast feeding; psychiatric disease or history of noncompliance which, in the investigator*s assessment would interfere with appropriate protocol treatment and monitoring.

发起方

niversitair Medisch Centrum Utrecht